[{"_id":"551f89b731cae9239deb1f22","会社名":"ゼリア新薬工業(株)【4559】","証券コード":"4559","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月13日","決算月数":"12か月","売上高":"61,996百万円","営業利益":"6,790百万円","経常利益":"6,803百万円","当期利益":"5,277百万円","EPS（一株当たり利益）":"115.01円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,105.78円","総資産":"99,493百万円","自己資本":"58,734百万円","資本金":"6,593百万円","有利子負債":"26,460百万円","自己資本比率":"59.0%","ROA（総資産利益率）":"5.94%","ROE（自己資本利益率）":"11.06%","総資産経常利益率":"7.66%","__v":0,"日付":"2015-04-04T06:50:31.354Z"},{"_id":"551f89b731cae9239deb1f23","会社名":"ゼリア新薬工業(株)【4559】","証券コード":"4559","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月16日","決算月数":"12か月","売上高":"53,317百万円","営業利益":"4,611百万円","経常利益":"4,676百万円","当期利益":"3,982百万円","EPS（一株当たり利益）":"96.32円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"888.41円","総資産":"78,246百万円","自己資本":"36,726百万円","資本金":"6,593百万円","有利子負債":"30,915百万円","自己資本比率":"46.9%","ROA（総資産利益率）":"5.19%","ROE（自己資本利益率）":"11.87%","総資産経常利益率":"6.09%","__v":0,"日付":"2015-04-04T06:50:31.355Z"},{"_id":"551f89b731cae9239deb1f24","会社名":"ゼリア新薬工業(株)【4559】","証券コード":"4559","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月15日","決算月数":"12か月","売上高":"53,169百万円","営業利益":"4,568百万円","経常利益":"4,417百万円","当期利益":"2,861百万円","EPS（一株当たり利益）":"69.19円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"734.06円","総資産":"75,201百万円","自己資本":"30,350百万円","資本金":"6,593百万円","有利子負債":"34,161百万円","自己資本比率":"40.4%","ROA（総資産利益率）":"3.84%","ROE（自己資本利益率）":"9.75%","総資産経常利益率":"5.93%","__v":0,"日付":"2015-04-04T06:50:31.355Z"}]